Skip to main content

Year: 2023

CN Recognizes 68 Customers, Suppliers and Supply Chain Partners under EcoConnexions Partnership Program

MONTREAL, Nov. 15, 2023 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today recognized 68 of its customers, suppliers and supply chain partners for their enhanced and continued commitment to sustainability. This year, CN extended the program to its suppliers in recognition of the pivotal role they play in supporting CN’s day-to-day operations and in the advancement of the Company’s sustainability ambitions. “CN is proud to celebrate the increased actions of our customers and supply chain partners who strive to operate more sustainably. Our aim is for CN’s EcoConnexions Partnership Program to be a vehicle of collaboration as we deepen relationships across our supply chain.”− Doug MacDonald, Executive Vice-President and Chief Marketing Officer “Engaging with our suppliers is critical to achieving CN’s sustainability goals. Sustainable...

Continue reading

Tims China Announces Third Quarter 2023 Financial Results

Record- high Quarterly Revenue of RMB436.4 Million Represents 42.7% Year-over-Year Growth Record-high Adjusted Store EBITDA Margin of 7.5% SHANGHAI, China and NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) — TH International Limited (Nasdaq: THCH), the exclusive operator of Tim Hortons coffee shops and Popeyes restaurants in China (“Tims China” or the “Company”) today announced its unaudited financial results for the Third quarter 2023. THIRD QUARTER 2023 HIGHLIGHTSTotal revenues reached a quarterly record of RMB436.4 million (USD59.8 million), representing a 42.7% increase from the same quarter of 2022.Net new store openings totaled 63 (14 company owned and operated stores and 45 franchised stores for Tims, 4 company owned and operated stores for Popeyes), resulting in 763 system-wide stores at quarter-end.Loyalty club grew to...

Continue reading

60 Degrees Pharma Announces Type C Meeting with FDA to Discuss Development of Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease

Type C meeting will be to discuss a proposed Phase II study of tafenoquine for treatment of babesiosis Transmitted by ticks, babesiosis is a life-threatening parasitic disease increasing in frequency in the United States Meeting with FDA scheduled for January 15, 2024WASHINGTON, Nov. 15, 2023 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted a Type C meeting with the Company to consult on the path forward in developing the tafenoquine regimen of ARAKODA® for a potential indication in treating hospitalized babesiosis patients. The meeting will take place on January 15, 2024. Tafenoquine is approved for malaria prophylaxis...

Continue reading

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Reported lead product candidate OCS-01 eye drop met both primary endpoints in Phase 3 OPTIMIZE trial for inflammation and pain after cataract surgery following positive readout of Stage 1 of the Phase 3 DIAMOND trial for diabetic macular edema (DME) Enrolled first patient in the investigator-initiated LEOPARD trial evaluating OCS-01 for treatment of cystoid macular edema (CME) Cash and investments of $116.5 million adequately funded to deliver on key business and clinical milestonesZUG, Switzerland and BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced third quarter financial results for the period ended September 30, 2023, and an overview of the Company’s progress. Riad...

Continue reading

Global-e Reports Third Quarter 2023 Results

PETAH-TIKVA, Israel, Nov. 15, 2023 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the global leader of Direct-To-Consumer cross border eCommerce enablement, today reported financial results for the third quarter of 2023. “The results of the third quarter of 2023 once again demonstrate the robustness of our business model, as evident from the top-line growth, improved profitability and our healthy pipeline,” said Amir Schlachet, Founder and CEO of Global-e. “We are excited about Shopify Markets Pro going into general availability in the US and remain focused on executing across all our strategic vectors, as we continue to capture the immense greenfield opportunity ahead of us.” Q3 2023 Financial ResultsGMV1 in the third quarter of 2023 was $839 million, an increase of 35% year over year Revenue in the third quarter of...

Continue reading

Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023

Reports 45% increase in domestic sales for the third quarter of 2023;new online store providing greater interaction with dentists and improved margins Gross profit margin increases to 73% for the third quarter of 2023, compared to 66% for the same period last year Medical division reports expansion of sales in a prominent hospital system, and pain management clinics Reports progress advancing reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended September 30, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved...

Continue reading

Crown Crafts Announces Financial Results for Second Quarter Fiscal 2024 and Declares Quarterly Dividend

GONZALES, Louisiana, Nov. 15, 2023 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported financial results for the second quarter of fiscal year 2024, which ended October 1, 2023. Second Quarter SummaryNet sales of $24.1 million in the current quarter, an increase of 28.9% over the prior yearGross profit was 27.3% of net sales in the current quarter, 29.1% in the prior-year quarterNet income in the current-year quarter of $1.8 million, or $0.18 per diluted share, compared with $2.0 million, or $0.20 per diluted share, in the prior-year quarterDeclared quarterly dividend of $0.08 per share of Series A common stock“Our increase in net sales for the second quarter of fiscal 2024 primarily reflects the acquisition of Manhattan Toy earlier in the year, and organic sales growth across our categories...

Continue reading

VPR Brands LP Announces Strong Financial Results for Q3 2023

The Company Reported a Net Income of $2,951,216 for Q3 2023, a Significant Turnaround From a Net Loss of $54,521 in Q3 2022 FORT LAUDERDALE, FL, Nov. 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – VPR Brands LP (OTC: VPRB), a market leader in the design, development, and licensing of trademarks and patents for electronic cigarettes, vaporizers, and related accessories, today announced its third quarter 2023 financial results. The company posted increased revenues and record profits as compared to previous quarters. Third Quarter 2023 Highlights:Revenues: Total revenues for Q3 2023 reached $3,540,409, a substantial increase from $1,231,057 in Q3 2022. This growth is primarily due to $2,735,224 in royalty revenues from the licensing of intellectual property. Cost of Sales: Cost of sales decreased to $570,124 from $813,252 in...

Continue reading

Southern Glazer’s Wine & Spirits and Symbotic Announce Agreement to Implement Industry-Leading Warehouse Automation Systems

MIAMI and WILMINGTON, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) — Southern Glazer’s Wine & Spirits (Southern Glazer’s) and Symbotic Inc. (Nasdaq: SYM), today announced they have entered into a strategic agreement and intend to deploy Symbotic’s A.I.-powered software and robotics warehouse automation systems in select Southern Glazer’s distribution centers. The companies have agreed to implement the first of these systems by 2025. Symbotic’s end-to-end automation system, with robotic case picking capabilities, enables Southern Glazer’s to transform these distribution centers to improve fill rates, order accuracy and customer service times, while extending the capacity and useful life of its existing facilities. The Symbotic System™ will build mixed-case pallets for efficient route-stop delivery and more efficiently...

Continue reading

RadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Thursday, November 16th

LOS ANGELES, Nov. 15, 2023 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Fall 2023 Conference on Thursday, November 16th at 1:00 p.m. Eastern Time. There will be simultaneous and archived webcasts available at https://sidoti.zoom.us/webinar/register/WN_w2qAiY-5QNGhgJt6cXReHw and www.radnet.com under the “About RadNet” menu section and “News and Press Releases” sub-menu of the website. Details for RadNet’s Presentation:Date: Thursday, November 16, 2023Time: 1:00 p.m. Eastern TimeURL: https://sidoti.zoom.us/webinar/register/WN_w2qAiY-5QNGhgJt6cXReHwAbout...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.